GI
NVO

GAMMA Investing’s Novo Nordisk NVO Stock Holding History

GAMMA Investing’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$622K Buy
12,971
+5,880
+83% +$253K 0.02% 557
2026
Q1 		$261K Sell
7,091
-2,152
-23% -$102K 0.01% 936
2025
Q4 		$470K Buy
9,243
+1,223
+15% +$62.5K 0.02% 552
2025
Q3 		$445K Sell
8,020
-1,103
-12% -$64.6K 0.02% 553
2025
Q2 		$630K Sell
9,123
-343
-4% -$23.3K 0.04% 402
2025
Q1 		$657K Buy
9,466
+1,605
+20% +$133K 0.05% 343
2024
Q4 		$676K Sell
7,861
-106
-1% -$11.5K 0.06% 290
2024
Q3 		$949K Buy
7,967
+817
+11% +$109K 0.09% 197
2024
Q2 		$1.02M Buy
7,150
+809
+13% +$107K 0.14% 127
2024
Q1 		$814K Buy
6,341
+856
+16% +$102K 0.17% 110
2023
Q4 		$629K Buy
+5,485
New +$542K 0.17% 97

Other funds holding NVO

SRIM
Saratoga Research & Investment Management Saratoga, California $1.83B AUM 18.41% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
QI
QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
OFA
Oak Family Advisors Chicago, Illinois $391M AUM 26.35% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
PFS
Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return

GAMMA Investing's NVO Position: Q2 2026 in Review

GAMMA Investing increased its Novo Nordisk (NVO) stake by 83% in Q2 2026, buying an estimated $253K and bringing the position to 12,971 shares worth $622K. The position accounts for 0.02% of the portfolio, ranked #557.

GAMMA Investing first reported a position in NVO in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.02M in Q2 2024. 387 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • GAMMA Investing held 12,971 shares of Novo Nordisk worth $622K as of Q2 2026.
  • GAMMA Investing bought 5,880 Novo Nordisk shares in Q2 2026, an estimated $253K.
  • Novo Nordisk made up 0.02% of GAMMA Investing's portfolio in Q2 2026, its #557 holding.
  • GAMMA Investing first reported a position in Novo Nordisk in Q4 2023 and has held it in 11 quarters since.
  • GAMMA Investing's Novo Nordisk position peaked at $1.02M in Q2 2024.
  • 387 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.